Charach Alice, Figueroa Max, Chen Shirley, Ickowicz Abel, Schachar Russell
Department of Psychiatry, The Hospital for Sick Children, Toronto, Ontario, Canada.
J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):415-21. doi: 10.1097/01.chi.0000199026.91699.20.
Long-term effects of psychostimulants on growth in height and in weight are investigated in children with attention-deficit/hyperactivity disorder.
Participants were 79 children, 6 to 12 years of age, with attention-deficit/hyperactivity disorder, who were followed annually for up to 5 years, between the years 1993 and 1994 and 1998 and 1999. Annual height and weight measurements were standardized by age and gender using the 2000 Centers for Disease Control and Prevention Growth Charts for the United States and reported as z scores. For children taking stimulants throughout the previous school year, dose potency was standardized to methylphenidate in milligrams per kilogram per day. We used hierarchical linear modeling to investigate the influence of dose and duration of stimulant treatment on the rate of growth in height and weight.
Controlling for time since initiation of treatment, daily dose of stimulant medication was negatively associated with z scores for height (beta = -.11, SE = 0.03, p <.01) and for weight (beta = -.29, SE = 0.04, p <.01). Estimates based on the statistical model suggest that children receiving > or = 1.5 mg/kg/day methylphenidate will show diminished weight gain after 1 year; those receiving > or = 2.5 mg/kg/day methylphenidate will show diminished gains in height after 4 years.
Long-term use of high doses of stimulants during a period of 1 to 5 years is likely to have measurable effects on the rate of growth in school-age children with attention-deficit/hyperactivity disorder.
研究精神兴奋剂对注意力缺陷/多动障碍儿童身高和体重增长的长期影响。
研究对象为79名6至12岁的注意力缺陷/多动障碍儿童,于1993年至1994年以及1998年至1999年期间,每年对其进行随访,最长随访5年。每年的身高和体重测量值根据年龄和性别,采用美国疾病控制与预防中心2000年生长图表进行标准化,并报告为z分数。对于上一学年全程服用兴奋剂的儿童,剂量强度按照每天每千克体重服用甲基苯丙胺的毫克数进行标准化。我们使用分层线性模型来研究兴奋剂治疗的剂量和持续时间对身高和体重增长率的影响。
在控制治疗开始后的时间因素后,兴奋剂药物的每日剂量与身高z分数(β = -0.11,标准误 = 0.03,p < 0.01)和体重z分数(β = -0.29,标准误 = 0.04,p < 0.01)呈负相关。基于统计模型的估计表明,接受≥1.5毫克/千克/天甲基苯丙胺治疗的儿童在1年后体重增加会减少;接受≥2.5毫克/千克/天甲基苯丙胺治疗的儿童在4年后身高增长会减少。
在1至5年期间长期使用高剂量兴奋剂可能会对患有注意力缺陷/多动障碍的学龄儿童的生长速度产生可测量的影响。